A comparitive study between two muscle relaxants.

Phase 4

Conditions: Health Condition 1: O- Medical and Surgical

Registration Number: CTRI/2023/08/056012

Lead Sponsor: Dr Thumu Jaisheel Gabriel Joseph

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. American society of Anaesthesiology score [ASA]

I and 2

2. Both Males and Females

3. Age between 18 years and 60 years

4. Patients requiring endotracheal intubation

undergoing General anaesthesia

5. Patients undergoing only Elective Procedures

Exclusion Criteria

1. Any systemic co-morbidity including uncontrolled hypertension and diabetes, Heart block, renal impairment (serum creatinine greater than 2mg/dl, hepatic impairment (trans-aminases greater than double the normal values), psychiatric disorders like Schizophrenia and Mania

2. Patient not giving consent

3. ASA Grade 3 and Grade 4 patients

4. Patients with history of Bronchial Asthma

5. Patient on any addictive drug or allergic to any drugs used in the trial

6. Pregnant patient and lactating mothers

7. Anticipated Difficult Airway (Mallampati Class III and IV, thyromental height < 6 cm, inter-incisor distance <3cm and cervical instability.)

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. To compare the effect of Muscle Relaxation between Atracurium & Cis Atracurium by comparing the ease of intubation <br/ ><br>2. To compare the change in haemodynamic parameters while using either Atracurium or Cis AtracuriumTimepoint: 10 minutes after induction

Secondary Outcome Measures

Name	Time	Method
1. To compare the Time interval for first maintenance dose between Atracurium & Cis atracurium <br/ ><br>2. To compare cost effectiveness between Atracurium & Cis atracuriumTimepoint: At baseline